Dexcom has received clearance for the first over-the-counter (OTC) glucose sensor in the U.S. The Food and Drug Administration cleared the device, Stelo, for use by people 18 years and older who are ...

This holiday season, the hottest electronic on sale at Best Buy just might be a continuous glucose monitor. The retail giant will soon begin selling the prescription-only devices through a new online ...

Earlier this year, while speaking with Fierce Medtech at the annual J.P. Morgan Healthcare Conference, Dexcom CEO Kevin Sayer noted that the continuous glucose monitor maker had recently changed its ...

BURNABY, British Columbia--(BUSINESS WIRE)--Dexcom, Inc. (NASDAQ: DXCM), a global leader in real-time continuous glucose monitoring (rtCGM) for people with diabetes, announced today that Health Canada ...

The US FDA has cleared a new “basal insulin dose optimizer” function for the Dexcom G7 15-day continuous glucose monitor (CGM), which is set to launch separately on December 1, 2025. The “Smart Basal” ...

Many have been following San Diego-based Dexcom’s partnership with Alphabet’s Verily, and in November the continuous glucose monitoring maker announced that it has changed the financial terms of the ...

This healthcare technology company is disrupting the diabetes market with innovative technologies that patients love. More than 34 million Americans have diabetes and an additional 88 million are at ...

The device is similar to existing prescription CGMs. Users pair the wearable sensor with an application, put it on their arm and receive a continuous stream of glucose data on their smartphone or ...